IFNA1 and hepatitis C virus infection: We experienced a patient who developed DM during IFN-α therapy for hepatitis C. Eleven patients with PM/DM (8 with PM and 3 with DM) related to IFN-α therapy, including our patient, have been reported (Table 1) [5–14].